Cannabinoids Clinical Trials Consumption Data 
NORML
FEBRUARY 25, 2020
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. These opioid-sparing effects were most pronounced among participants who had prior experience with cannabis.
Project CBD
MARCH 21, 2023
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
APRIL 12, 2023
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. Over 31 days, 388 people reported on their sleep before and after trialing the CBN product.
Project CBD
AUGUST 6, 2019
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
Cannabis Law Report
FEBRUARY 2, 2022
The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. hours after consumption. hours after consumption. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.
Veriheal
MAY 3, 2022
The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. Clinical Trial Sample Size. Investigating the Impact of MMJ Cards. a necessary question to address as medical marijuana becomes more accessible.
Project CBD
AUGUST 6, 2019
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
Expert insights. Personalized for you.
239 
Let's personalize your content